Skip to main content

Table 3 Patient and tumour characteristics

From: Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies

  

PTC

FTC

MTC

ATC

All tumours

Total no.

 

19

21

8

8

56

Sex (male/female)

 

4/15

8/13

5/3

3/5

20/36

Age at diagnosis

mean

53.6

60.5

58.1

74.1

59.8

(years)

median

50.4

60.6

60.5

75.8

60.8

Living/died/unk.

 

17/2/0

16/3/2

2/6/0

1/6/1

36/17/3

Survival of those

mean

153.3

16.8

81.3

4.7

49.5

who died (months)

median

153.3*

11.2*

95.2

1.6

7.7

Tumour diameter

mean

2.2 (n = 14)

3.0 (n = 15)

4.5 (n = 4)

6.4 (n = 4)

3.2 (n = 37)

(cm)

median

1.8

2.5

3.3

5.5

2.5

pT (number)

1

9

7

1

0

17

 

2

6

6

1

0

13

 

3

2

6

3

1

12

 

4

0

0

1

6

7

 

unk.

2

2

2

1

7

pN (number)

0

8

5

0

0

13

 

1

1

3

4

1

9

 

unk.

10

13

4

7

34

pM (number)

0

7

4

0

2

13

 

1

1

5

3

2

11

 

unk.

11

12

5

4

32

  1. ATC Anaplastic thyroid carcinoma, FTC Follicular thyroid carcinoma, MTC Medullary thyroid carcinoma, PTC Papillary thyroid carcinoma, pT, pN, pM: TNM classification according to the pathology report; unk.: unknown. *: Please note that in PTC and FTC the median survival time was not reached due to only a few patients who died during the observation period (see Fig. 1)